SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-184765
Filing Date
2023-07-10
Accepted
2023-07-10 17:20:29
Documents
15
Period of Report
2023-07-07
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d523471d8k.htm   iXBRL 8-K 26933
2 EX-16.1 d523471dex161.htm EX-16.1 4737
6 GRAPHIC g523471g0705211131994.jpg GRAPHIC 715
7 GRAPHIC g523471g0705211132124.jpg GRAPHIC 2077
  Complete submission text file 0001193125-23-184765.txt   159750

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA txmd-20230707.xsd EX-101.SCH 2872
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20230707_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20230707_pre.xml EX-101.PRE 11276
9 EXTRACTED XBRL INSTANCE DOCUMENT d523471d8k_htm.xml XML 3347
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 231080599
SIC: 2834 Pharmaceutical Preparations